334 related articles for article (PubMed ID: 33688252)
1. Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.
Li L; Huang H; Zhu M; Wu J
Cancer Manag Res; 2021; 13():2095-2104. PubMed ID: 33688252
[TBL] [Abstract][Full Text] [Related]
2. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract][Full Text] [Related]
3. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
[TBL] [Abstract][Full Text] [Related]
4. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
5. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
6. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
7. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.
Lv Q; Liu Y; Huang H; Zhu M; Wu J; Meng D
Onco Targets Ther; 2020; 13():5541-5550. PubMed ID: 32606769
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
Yuan Q; Zheng L; Liao Y; Wu G
World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
[TBL] [Abstract][Full Text] [Related]
10. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.
Ren Y; Deng R; Zhang Q; Li J; Han B; Ye P
Ann Transl Med; 2020 Dec; 8(24):1637. PubMed ID: 33490149
[TBL] [Abstract][Full Text] [Related]
12. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
14. [Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].
Wang Y; Wang YS; Hu NB; Teng GS; Zhou Y; Bai J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):804-812. PubMed ID: 35680809
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
[TBL] [Abstract][Full Text] [Related]
16. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
Zhai X; Yang Z; Liu X; Dong Z; Zhou D
PeerJ; 2020; 8():e9975. PubMed ID: 33005492
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
18. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
Zhao DD; Zhao X; Li WT
Int J Ophthalmol; 2020; 13(7):1046-1053. PubMed ID: 32685390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
